Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

Finger-prick dried blood sampling can accurately measure key Alzheimer’s disease biomarkers, including p-tau217, GFAP, and ...

Background Inflammatory bowel disease (IBD) arises from complex interactions among diet, host and gut microbiome. Although diet influences intestinal inflammation, the microbial and metabolic pathways ...

Learn how acceptance sampling improves quality control by evaluating random samples. Discover its methods, benefits, and historical significance in manufacturing.

Torrent Consulting's Salesforce capabilities will augment ZS's healthcare expertise and AI innovation to deliver measurable value for patients, providers and life sciences organizations EVANSTON, Ill.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm ...

Zscaler (ZS) has beaten earnings estimates for eight consecutive quarters by an average of 24%. Zscaler reported 76% gross margin last quarter but operating margin remains negative at 4.5%. The ...

Acknowledging that the city cars and superminis don’t really suit plug-in hybrid powertrains, MG will turn its attention to the small-SUV segment instead. “I think [B-segment SUVs] are the next ...

Australian details for the 2026 MG ZS small SUV have been announced ahead of local showroom arrivals at a later date. MG Motor Australia has confirmed that the ZS line-up will be reduced for 2026, ...

The 2025 MG ZS small SUV has gained a more affordable turbocharged petrol variant, ahead of a safety update expected to arrive in Australia by the end of the year. On sale now, the ZS Vibe Turbo cuts ...

Already-spoiled buyers in the compact SUV segment will have to further lengthen their shopping lists with the arrival of the MG ZS Pro. The MG ZS Pro is effectively the replacement for the aging ZS.

Zscaler earns a buy rating for its strong fundamentals, consistent double beats, and robust revenue growth, despite ongoing share dilution and premium valuation. ZS's Q4 results highlight impressive ...